Dr. Marty Lerner discusses the evolving role of GLP-1 receptor agonists in treating eating disorders and food addiction. He explores how these medications reduce cravings, influence satiety, and their clinical and ethical implications. Dr. Lerner also highlights potential benefits, risks, and the importance of addressing emotional and psychological aspects in recovery.
Michael Prager, author of Fat Boy, Thin Man, shares his journey from food addiction to recovery and advocacy. He discusses the inspiration behind his books, the parallels between food and substance addiction, and the need for institutional recognition of food addiction. A must-listen for anyone seeking insights into recovery and systemic change.
The Future of Ultra-Processed Food Use Disorder & Eating Disorder Treatment Dr. Kim Dennis discusses the growing recognition of Ultra-Processed Food Use Disorder (UPFUD) and its impact on mental health. Citing a major study linking UPFA to cardiovascular disease, diabetes, and anxiety, she challenges the “all foods fit” model in eating disorder treatment. At her […]
Slips, lapses, recurrences, and relapses s "all or nothing" the only way to recover from Ultra-Processed Food (UPF) addiction, or is there a more flexible, compassionate approach? In this episode, […]
In this episode of the Food Junkies Podcast, Dr. Vera Tarman interviews Dr. John Davis about how bariatric surgery may increase the risk of alcohol use disorder and food addiction. […]
